Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 250 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-09-24 | 2020-12-17 | 125013 |
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-04-15 | 2022-01-28 | 137544 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-10-21 | 2021-11-11 | 147711 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-01-20 | 2022-03-09 | 153177 |
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-06-30 | 2023-04-28 | 163942 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-06-30 | 2023-04-28 | 163945 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-06-08 | 2023-08-18 | 194116 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-06-16 | 2023-07-05 | 195177 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-01-25 | 2024-03-21 | 217226 |
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-01-25 | 2024-03-14 | 217229 |
| TEVA-OMEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-01-25 | 2024-05-23 | 217231 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-10-02 | 2019-02-01 | 24103 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-10-02 | 2019-02-01 | 24106 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2019-07-02 | 2019-08-10 | 88213 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2019-12-12 | 2020-03-12 | 101148 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107989 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2020-03-26 | 2020-07-23 | 109565 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2020-04-02 | 2020-07-23 | 110661 |
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2020-07-16 | 2020-09-25 | 120453 |
| TEVA-OXYCOCET | 5MG 325MG | TABLET | Resolved | 2021-01-07 | 2021-02-05 | 131078 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |